Cargando…
Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination
Despite tremendous development in chemotherapy for ovarian cancer over the past few decades, the prognosis of advanced cases with massive peritoneal dissemination is still unsatisfactory, and novel treatment modalities that can combine with chemotherapy are urgently needed. We recently developed vir...
Autores principales: | Takakura, M, Nakamura, M, Kyo, S, Hashimoto, M, Mori, N, Ikoma, T, Mizumoto, Y, Fujiwara, T, Urata, Y, Inoue, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834363/ https://www.ncbi.nlm.nih.gov/pubmed/19662088 http://dx.doi.org/10.1038/cgt.2009.44 |
Ejemplares similares
-
Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers
por: Takakura, M, et al.
Publicado: (2012) -
Boosting Replication and Penetration of Oncolytic Adenovirus by Paclitaxel Eradicate Peritoneal Metastasis of Gastric Cancer
por: Ishikawa, Wataru, et al.
Publicado: (2020) -
Detection of circulating tumor cells in cervical cancer using a conditionally replicative adenovirus targeting telomerase‐positive cells
por: Takakura, Masahiro, et al.
Publicado: (2017) -
Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system
por: Aoyama, Katsuyuki, et al.
Publicado: (2017) -
The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses
por: Tate, Sophia J., et al.
Publicado: (2021)